Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC).
| Image |  |
|---|---|
| Description | scientific article published on 03 October 2014 |
| Author/s | |
| Publication date | October 3, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |